Dentinogenic ghost cell tumors (DGCTs) are uncommon neoplasms classified as a solid variant of the calcifying odontogenic cyst and defined as a locally invasive neoplasm. It can occur in two forms: Intraosseous (central) and extraosseous (peripheral). The objective of the present article was to present a bibliometric review of the published cases of central and peripheral variants of the DGCTs, with emphasis on their epidemiology, biological behavior, and immunohistochemical profile. The present review includes published cases of DGCTs collected through PubMed and ScienceDirect databases.
Introduction
Dentinogenic ghost cell tumor (DGCT) presents as a rare invasive neoplasm characterized by islets of ameloblastoma-like epithelial cells in mature connective tissue. Aberrant keratinization can be found in the form of ghost cells in association with varying amounts of dysplastic dentin. [1] [2] [3] [4] [5] [6] [7] [8] [9] DGCT was considered a solid variant of the calcifying odontogenic cyst (COC) by Praetorius et al. [10] DGCT transforming into squamous cell carcinoma and ghost cell odontogenic carcinoma (GCOC) has also been reported. [11] [12] [13] The DGCT presents mostly as an intraosseous tumor involving canine-first molar region. The peripheral variant is relatively rare and presents in the anterior region of the mandible. [1, [14] [15] [16] [17] [18] [19] Most patients belong to the second to the ninth decade of life. DGCT has shown to have a strong male predilection. [1, [20] [21] [22] [23] [24] [25] Intraosseous DGCTs are highly aggressive and are prone to local recurrence. Few cases of distant metastasis have also been reported in central DGCT. In contrary, the peripheral variant is relatively dormant. Given its aggressive course, intraosseous DGCTs are treated by radical resection with adequate safety margins, while the peripheral variant has a relatively conservative treatment approach. [26] [27] [28] [29] The objective of this review was to present a bibliometric review of the published cases of DGCT. Details retrieved from the published cases included the epidemiology, clinical behavior, microscopic characteristics, and immunohistochemical profile.
Materials and Methods

Data collection methods
An electronic search without any date restriction was undertaken from April to July 2018 on all published cases of DGCT through the PubMed and ScienceDirect platforms. They were searched using the words calcifying ghost cell odontogenic tumor, COC, DGCT, Gorlin tumor, and odontogenic ghost cell tumor. The bibliography of all selected articles was cross-referred to identify potential articles. The search strategy of the review is represented in Figure 1 .
The review included all articles (original studies, case reports, and series) in the English language that provided sufficient clinical, radiological, and histopathological details to confirm the diagnosis of DGCT. Exclusion criteria included lack of vital details necessary to confirm the DGCT diagnosis. All review articles and article not in the English language were excluded from the study.
A total of 48 articles were identified reporting a total of 75 DGCT cases. Four of the 48 articles were removed as they did not comply with the inclusion criteria, resulting in a total of 57 DGCT cases. For each study included, the following data were extracted in a standard way: Authors' name and year of publication, continent, and country where the study was conducted; number of reported cases; age and gender of the patient; duration of the lesion before treatment (months); and anatomical location (maxilla/ mandible); symptomatology (Asymptomatic/symptomatic); type of signs and symptoms (clinically); lesion size; recurrence (yes/no); follow-up period; and immunohistochemical profile. All included DGCT cases were reevaluated using the WHO 2017 classification for odontogenic tumors.
Results
The present study analyzed 57 published cases of DGCT, of which 39 (68%) were central type and 18 (32%) were peripheral variant. The mean age of the patients was 45.33 years (standard deviation [SD] 21.07 years; range 7-82 years). There was a strong male predilection with 68% of cases occurring in men. The average time of tumor progression was 14.00 months (SD, 21.45 months). The most common location for both the central and peripheral variants of DGCT was the mandible (60%) followed by the maxilla (40%). A majority of published DGCT cases were reported in the Asian population (65%). Table 1 . The highest prevalence occurred during the fourth decade of life. About 69% of cases occurred in men. Central variant showed a greater predisposition to the mandible than the maxilla. Clinically, DGCT usually presented as a swelling with slight or mild pain, which increased steadily in size (for several months or years). The average progression time of the peripheral variant was 13.67 months ± 21.47 (range 1-84 months). Thirteen cases (33%) showed recurrence.
Clinical characteristic of central DGCT
Summary of the demographic and clinical details of the 39 central DGCT is presented in
Clinical characteristic of peripheral DGCT
Summary of the demographic and clinical details of the 18 peripheral DGCT is presented in Table 2 . The highest prevalence occurred during the fifth decade of life, which was one decade older than the central variant. About 67% of the cases occurred in men. The average progression time of the peripheral 
Histopathological characteristics of central and peripheral DGCT
Both central and peripheral DGCT exhibited odontogenic epithelium with areas resembling ameloblastoma, microcystic spaces, basaloid hyperchromatic and isomorphic cells, aberrant keratinization with occasional calcification, ghost cells, multinucleated giant cells, dentinoid or osteodentinlike material, and mature connective tissue mixed with the main odontogenic epithelial component and mitotic figures. Table 3 . Immunohistochemistry (IHC) investigation was performed in 10 cases. The applied markers, as well as its reactivity and location, are enlisted in Table 4 .
Discussion
DGCT is an extremely rare solid variant of the COC. COCs represent only 1-2% of all odontogenic cysts and only 2-14% of them are DGCTs. The literature on DGCT is relatively scarce with most published data in the form of individual case reports. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Thus, a comprehensive review will aid in understanding the complex morphological characteristics and behavioral pattern of DGCT. [38] [39] [40] Variations in the nomenclature of the lesion can be observed in literature, which can be attributed to DGCT relation to the COC and the predominance of ghost cells. To include all published cases of DGCT, the present review included several keywords including calcifying ghost cell odontogenic tumor, COC, DGCT, Gorlin tumor, and odontogenic ghost cell tumor. [1, [41] [42] [43] [44] [45] [46] [47] As mentioned earlier, DGCT is reported as a central tumor and a less common peripheral variant. [20, 29, 31, 45, 48, 49] In an update by Buchner et al., most cases of DGCT (66%) were found in the Asian population. [46] Corroborating with this study, a majority of cases (65%) included in the present review were from Asia (China, Japan, South Korea, and India, among others). Most of the included studies noted that the central variant had a maxillary predisposition and a male predilection with a peak age of incidence during the fourth decade of life. Being a relatively aggressive tumor, patients often present mandibular expansion, swelling and have shown larger growth occupying almost the entire mandible. [37] Despite the growth pattern, the tumor is asymptomatic in 33% of cases and is often identified during the routine radiographic investigation. Radiographically, it may present as a well-defined or poorly demarcated unilocular or multilocular lesion. Depending on the amount of calcification, the tumor may be radiolucent, radiopaque, or mixed. Root resorption and the presence of retained teeth were also reported in relation to DGCT. [6, 27, 41, 52] The peripheral type occurs significantly later in life (fifth decade) than the central type and affects the mandible more than the maxilla. It presents typically as exophytic nodules in the gingiva or alveolar mucosa. [7, 19] A majority of the peripheral variant (67%) are asymptomatic.
Histopathologically, DGCT presents as islands of epithelial cells with ameloblastoma like basal cell layer, which may show nuclear polarization. A central component of the epithelial obliteration of the maxillary sinus, or infiltration of the soft tissues, dental displacement, or mobility. [17, 23, 50, 51] In general, these tumors do not exceed 6.5 cm, with a mean of 4.28 cm, although rare cases islands bares resemblance to the stellate reticulum of the enamel organ. Characteristically, it contains varying amounts of dentin-like material in the surrounding connective tissue and in close contact with the epithelial islands. In addition, ghost cell groups within the epithelial islands could be found [6, 7, 9, 46] [ Figure 2 and 3]. All 57 cases analyzed in this study presented ghost cells and dentinoid material. In 89% of the cases, the odontogenic epithelium had areas resembling ameloblastoma, 12% had microcystic spaces, 19% had basaloid cells, 18% had multinucleated giant cells, 70% had aberrant keratinization and occasional calcification, 9% had mature connective tissue mixed with odontogenic epithelium, and 4% of cases contained mitotic figures. According to the WHO, the presence of ghost cells and dentinoid is vital for the diagnosis DGCT. [51] These characteristics features (ghost cells and dentinoid) were present in all the included cases [ Table 3 ]. The use of comprehensive immunohistochemical panel consisting of several markers aids in understanding the molecular profile of the disease entity. For DGCT, the immunohistochemical profile consisted of MIB-1, KP1, S-100, p63, and AE1/AE3 [ Figure 4 -7]. Piattelli et al. [38] attempted to correlate proliferation and apoptosis markers such as MIB-1, bcl-2, and p53 to the aggressiveness and malignant potential of DGCT [ Figure 5 ]. p63 gene expression in DGCT was noted in the epithelium component resembling the dental lamina [ Figure 7 ]. The p63 gene is a homolog of the p53 tumor suppressor gene and is expressed with increased intensity in the basal progenitor layers of many epithelial tissues. Unlike p53, the p63 gene encodes multiple isotypes capable of activating p53 and inducing apoptosis. Loss of expression of this gene has been associated with neoplastic progression in cases of bladder cancer. [53, 54] The correlation of its expression in DGCT, therefore, denotes a good differentiation of the neoplastic process because the expression of this gene is characteristic of squamous cells.
In a study by Pulino et al. [8] evaluating the expression of proliferating cell nuclear antigen (PCNA), p53, and Ki-67 antigens in three DGCT cases showed that PCNA was expressed mainly in the basal layer, p53 labeling appeared weak in all cases. Ki-67 was expressed by few cells of the odontogenic epithelium.
Overall, there was no correlation between the proliferative activity and the biological behavior of the tumor.
The characterization of the type of odontogenic epithelium of DGCT was determined by the interpretation of the predominant type of cytokeratin in the tumor epithelium. CK-7 has high molecular weight, whereas AE1/AE3 is markers for a broad spectrum of low molecular weight cytokeratins. The immunohistochemical of DGCT demonstrates the greater immunoreactivity of the tumor epithelium for the AE1/AE3 cytokeratins [ Figure 4 ]. Other studies have shown similar labeling, Lukinmaa et al. [55] demonstrated that the lesion epithelium has immunoreactivity for low molecular weight and high molecular weight cytokeratins using PKK1 and 34βE12, respectively. In the study by Piattelli et al., [38] intense labeling for AE1/AE3 was described in the central portions of the ghost cells.
The main histological component of DGCT was the odontogenic epithelium. Epithelial cells can express CK-5, CK-7, CK-14, and CK-19. [51] In a retrospective study, da Silva et al. [56] compared the histological pattern and syndecan-1 and Ki-67 immunoexpression on a series of ghost cells, which are associated with tumor invasion in some benign and malignant tumors. The study included 21 odontogenic central calcific odontogenic tumors (CCOTs), four associated with odontoma, two peripheral CCOTs, one DGCT, and one GCOC. It was observed that the central stellate like epithelium expressed syndecan-1 more frequently than basal cells. Although there were some differences in the number of tumors expressing syndecan-1 in each histological component, statistically significant differences were not found. The Ki-67 marking index showed an average of 4.1%, with the Ki-67 marking index being prominent in GCOC and, surprisingly, also relatively high in CCOTs, but not observed in DGCT.
Gong et al. [57] investigated histopathological characteristics and expression of nuclear factor kB (NF-kB), Ki-67, and matrix metalloproteinase-9 (MMP-9) in the COC, CCOT, DGCT, and GCOC. The histopathological characteristics and expression of NF-kB, Ki-67, and MMP-9 were correlated with tumor proliferation and invasion. The Ki-67 mean of GCOC was found to be significantly higher than those of CCOT and DGCT, which suggested that Ki-67 was useful for judging COC malignancy. No significant difference was found between Ki-67 expression in CCOT and DGCT in the study. They found that NF-κB was mainly expressed in the COC cytoplasm as well as in classical ameloblastoma with only a few nuclear stains, implying that NF-κB is inactive and may rarely influence COC progression. In the study, immunostaining and in situ hybridization for MMP-9 expressed in both tumor cells and stromal cells were found in most cases of COC. Expression of the MMP-9 protein in GCOC stroma cells was significantly higher than that of stromal cells from CCOT and DGCT, but the number of cases is limited and expression is varied. Further studies are needed to establish the role of MMP9 in the progression of odontogenic tumors. In the case reported by Soares et al., [37] it shows intense and diffuse positivity for cytokeratins AE1/AE3. CK-7 was focally expressed in reticulum-like areas and pseudoductal spaces, which also showed positivity for CK-14 and CK-19. The cell proliferation index assessed by Ki-67 was <1%. CD138 was predominantly positive on the cell membrane of tumor epithelial cells and resembles the stellate reticulum of the enamel organ.
Unlike most odontogenic tumors, the pathogenesis of DGCT remains relatively unexplored. [23, 25] Kim et al. [34] in their study investigated the β-catenin gene in the case of DGCT. IHC showed nuclear, cytoplasmic, and membranous β-catenin accumulation in tumor cells. TUNEL assay showed positive signals in nucleated cells adjacent to ghost cells. DNA sequence analysis showed a wrong sense mutation at the codon of three β-catenin genes. The DNA extracted from the normal mucosa did not show any β-catenin mutation, excluding the presence of polymorphisms. Thus, it was interpreted that mutation in β-catenin plays an important role in the tumorigenesis of DGCT by a process of inappropriate differentiation coordinated by the Wnt signaling pathway. Further studies are needed to determine the genotypic/phenotypic characteristics of odontogenic lesions containing ghost cells. Table 4 summarizes the IHC findings of all DGCT cases with IHC investigation. Some IHC studies were performed comparing the DGCT with odontogenic cysts such as CCOT and GCOC. Based on the results of the included studies, IHC panel can be considered as a vital diagnostic and prognostic tool for DGCT, especially in difficult cases, where there is a limited sample or borderline morphology.
Early diagnosis is essential to ensure good prognosis in aggressive tumors like DGCT. The treatment is different for both variants of DGCT due to the difference in recurrence rate and malignant potential. [9] The treatment of choice for peripheral DGCT is local excision. Although treated conservatively, the peripheral variant does not show recurrence. [15, 24, 33, 42] Central DGCT is considered locally aggressive neoplasm with a recurrence rate of 73% following conservative surgical treatment of enucleation or curettage compared to 33% recurrence rate after radical treatment of peripheral or segmental resection. Recurrence occurred from 1 to 20 years after the initial surgery. [46, 51] Of the 39 cases of central DGCT analyzed in the present review, 33% presented recurrence of the treatment, corroborating with literature. The recurrence rate mentioned above is only tentative, as most of the included cases in the review were of case reports and in most occasions, cases with recurrence are often preferred for publication, which, in turn, could cause an overestimation bias of the recurrence. Since conservative curettage and enucleation were not adequate, intraosseous DGCT should be treated with resection with an adequate safety margin of at least 0.5 cm, similar to recommendations for ameloblastoma. Nevertheless, some cases were treated with surgical enucleation without any recurrence reported to date. [9, 20, 30, 36, 43, 45] Recurrent DGCT tumors have shown to exhibit malignant characteristics such as increased cellular and nuclear pleomorphism with more frequent mitotic figures. These malignant counterparts are diagnosed as GCOC. GCOC is a particularly rare malignant counterpart of DGCT. About 32.5% of GCOCs are derived from DGCT or COC. Given the rarity, atypical histological characteristics and malignant potential of DGCT, it may be necessary for a long period of clinical, radiographic, and histopathological follow-up. [5, 12, 13] Recently, a review was conducted by de Arruda et al., [58] in which 466 published cases of the COC, DGCT, and GCOC were analyzed, with clinical-radiological characteristics, treatment, and recurrence. Among the 466 cases, 55 cases were identified as DGCT. The present review included 57 cases of DGCT. The difference in the number of cases between Arruda et al. and the present review could be a result of varying inclusion and exclusion criteria and the type and period of the database search. In the present review, in addition to analysis of the epidemiological and characteristic data, other vital components including recurrence, follow-up period, histopathological, and IHC characteristics were also analyzed.
Conclusion
The present review was undertaken to provide a comprehensive update on the epidemiological, clinicopathological, and IHC profile of DGCT with emphasis on its recurrence and malignant potential. Based on the information collected from the included cases, DGCT must be considered as an aggressive tumor with potential for malignant transformation. Recurrence is relatively more common in central DGCT, especially in cases which are treated conservatively. Thus, it is vital that central DGCTs are diagnosed early and are treated aggressively to prevent a recurrence. Given the increasing application of artificial intelligence (AI) in medicine, there is an increasing demand for the collection of raw data to be fed into the AI systems. Data collected through a comprehensive review on the clinicalpathological features of unique entities such as DGCT could be a vital source of raw materials for the AI. [59, 60] 
